The positional stability of the catheters and the resultant dosimetric variation over a period of time is studied and presented. The ability of brachytherapy to deliver high radiation doses over a short time period means patients can complete treatment in days rather than weeks required for EBRT. Brachytherapy is generally well tolerated with a good toxicity profile for many of its applications, largely due to its tissue sparing approach. The remote after-loading HDR Brachytherapy treatment unit Gamma Med iX plus (Varian Medical Systems, Palo Alto, CA) or Microselectron HDRV3 (Nucletron, BV) using single sealed Iridium 192 radioactive source was used for treatment and for treatment planning, Eclipse (Varian Medical Systems, Palo Alto, CA) or Oncentra Master plan (Nucletron, BV) was used. Interfraction errors occur frequently in interstitial HDR brachytherapy. If no action is taken it will result in a significant risk of geometrical miss and overdose to the organs at risk. The effect of interfraction variation also depends on the fractionation schedule of the brachytherapy treatment. It is recommended to complete the treatment within 5 days. For cancer cervix (MUPIT) interstitial implant planning before each fraction is recommended.
Author(s) Details:
Saravanan Kandasamy,
Department of Radiotherapy, Regional Cancer Centre, JIPMER, Puducherry, India.
K. S. Reddy,
Department of Radiotherapy, Regional Cancer Centre, JIPMER, Puducherry, India.
Vivekanandan Nagarajan,
Medical Physics Department, Cancer Institute (WIA), Adyar, Chennai, India.
Parthasarathy Vedasoundaram,
Department of Radiotherapy, Regional Cancer Centre, JIPMER, Puducherry, India.
Gunaseelan Karunanidhi,
Department of Radiotherapy, Regional Cancer Centre, JIPMER, Puducherry, India.
Please see the link here: https://stm.bookpi.org/ANUMS-V10/article/view/13926
No comments:
Post a Comment